CDH2 and cancer: During EMT, epithelial cells transform from epithelial cells highly expressing epithelial markers (E-cadherin) to mesenchymal cells overexpressing mesenchymal markers (N-cadherin and Vimentin), which then promote the migration and invasion of cancer cells [32].